Valspec’s Nimit Amipara, together with Genentech’s Tiffany Button, discussed the ambitious new validation processes that trimmed plant completion from five or more years to only two and a half. Genentech and Valspec, a provider of system validation and lifecycle services, implemented an innovative commissioning and qualification strategy based on their detailed knowledge of Emerson’s solutions and industry best practices.
Latest News
Emerson Ventures Invests in Symmera
Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...
Emerson Ventures Invests in First Resonance
Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System
Emerson Ventures Makes Strategic Investment in Spearix
Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
